Objective: Injuries to the avascular regions of the meniscus fail to heal and so are treated by resection of the damaged tissue. This alleviates symptoms but fails to restore normal load transmission in the knee. Tissue engineering functional meniscus constructs for re-implantation may improve tissue repair. While numerous studies have developed scaffolds for meniscus repair, the most appropriate autologous cell source remains to be determined. In this study, we hypothesized that the debris generated from common meniscectomy procedures would possess cells with potential for forming replacement tissue. We also hypothesized that donor age and the disease status would influence the ability of derived cells to generate functional, fibrocartilaginous matrix.
Introduction
The meniscus is a fibrocartilaginous tissue vital to knee function 1e5 . Aligned collagen bundles within the meniscus 6 bear tensile hoop stresses that are generated with load transmission across the tibiofemoral joint 7 . These stresses are resisted with little deformation 8 by the high tensile properties in the circumferential direction, which range from 50 to 250 MPa depending on age, species, and testing parameters 1,9e13 . The meniscus is sparsely colonized by a heterogeneous cell population which continually maintains and remodels the extracellular matrix (ECM) 14, 15 . Meniscus cells transition from a fibrochondrocyte-like phenotype in the avascular inner region to a more fibroblastic phenotype in the outer rim, with ECM deposition reflective of this transition (i.e., a mix of type I and type II collagen and aggrecan in the inner zone and type I collagen in the periphery) 14,16e24 . While the meniscus functions well with a lifetime of use, traumatic or degenerative injuries to the avascular, inner region fail to heal 25 . Disruption of the fibrous architecture impairs load transmission 8, 26, 27 and initiates erosion of the adjacent articular surfaces, or osteoarthritis (OA) 28e31 . Currently, damage to the inner zone of the meniscus is treated by resection via arthroscopic partial meniscectomy, which alleviates symptoms but similarly predisposes patients to OA. Tissue removed in this procedure is deemed surgical waste and is discarded at the time of surgery. Studies following patient outcomes after partial meniscectomy indicate that resection of larger portions of meniscus results in more rapid cartilage erosion 32, 33 . Adverse changes in cartilage (as indicated by radiographic joint space narrowing) are noted within a 5e10-year period post-meniscectomy 30 . This long duration before clinical symptoms arise creates a unique window of opportunity for the application of regenerative strategies to restore meniscus function and avert the onset of OA.
Over the last two decades, a number of tissue engineering strategies have emerged to replace all or part of the meniscus to improve immediate and long-term patient outcomes (reviewed in Refs. 34e36). For example, cell-free hydrogels have been implanted in place of an entire meniscus in rabbit and sheep models 37, 38 . A variety of degradable porous foams have been developed 39, 40 , some incorporating anchors for fixation to the tibial plateau 41 , or carbon fibers to instill directionality 42 . More recently, efforts have focused on natural materials such as subintestinal submucosa 43, 44 as well as collagen-and tissue-based implants 45e49 . Many of these studies employing in vivo animal models reveal that some chondroprotection is afforded by the implant, but none to date have been able to recapitulate native mechanical properties or completely abrogate cartilage degeneration 50 . To advance the field of meniscus repair, we have investigated the use of nanofibrous scaffolds combined with meniscal cells or mesenchymal stem cells (MSCs) for meniscus tissue engineering 51, 52 . This strategy is founded on electrospinning, a scaffold fabrication technique that generates nanometer diameter fibers through an electrostatic process 53, 54 . While numerous biologic and synthetic polymers can be electrospun (see Ref. 54 for review), we fabricate nanofibrous scaffolds using poly(3-caprolactone) (PCL), a slowly degrading polyester. This polymer was chosen as it maintains its form in a physiologic environment and can thus direct tissue formation over a long period oftime (as cells deposit new ECM), as well as deform elastically over physiologic ranges experienced in the meniscus 55 . These fibers can further be arranged into parallel arrays 51, 52, 56, 57 , creating an architecturally and mechanically anisotropic micro-pattern conducive to organized tissue growth. In a recent study, we showed that young bovine meniscal cells aligned with and deposited ECM in the predominant fiber direction of these anisotropic scaffolds, and that this matrix deposition improved the construct tensile properties with time in culture 52 . Such constructs, that possess architectural and mechanical features similar to the native tissue, may better restore meniscus mechanics and load transmission in vivo, averting the onset of OA after meniscus repair.
To move this technology closer to clinical implementation, this study focused on the potential of human meniscus derived cells (MDCs) isolated from surgical debris from patients undergoing either partial meniscectomy or total knee arthroplasty (TKA). Isolation of cells from native meniscus tissue has a number of advantages; the cells have the appropriate phenotype, would be autologous thus limiting immune responses, and require no secondary surgical site. In this study, we utilized cells derived from 10 patients spanning a range of ages (18e84 years old) and disease conditions (traumatic or degenerative meniscus lesions, or OA of the entire joint). It has previously been shown that increases in organism age limits the ability of chondrocytes from articular cartilage to form functional ECM 58, 59 . Further, when age-matched chondrocytes derived for autologous chondrocyte implantation procedures were compared between normal and osteoarthritic donors, cells from diseased tissues showed a markedly lower ability to form collagen-rich ECM 60 . Meniscus cells are related to chondrocytes (particularly for the samples acquired from the inner avascular region of the meniscus), and so we hypothesized that while all surgical specimens would yield viable human cells, their ability to deposit functional fibrocartilaginous ECM and improve scaffold properties would depend on the donor age and/or disease status. To test this hypothesis, MDCs were seeded onto aligned nanofibrous scaffolds, cultured in a chemically defined chondrogenic medium, and biochemical, histological, and mechanical properties were evaluated over a 10-week time course.
Materials and methods

SCAFFOLD FABRICATION
For each donor, a separate aligned, nanofibrous mesh was produced via electrospinning 51, 52 . Briefly, a 14.3% w/v solution of PCL (80 kD, SigmaeAldrich, St. Louis, MO) was dissolved in a 1:1 solution of tetrahydrofuran and N,N-dimethylformamide (Fisher Chemical, Fairlawn, NJ). The solution was electrospun onto a grounded mandrel (1 00 diameter, 8 00 length) rotating at a velocity of w10 m/s 51 . For each production run, nanofibers were collected for 8 h, resulting in a fiber mats with an average thickness of 0.865 AE 0.177 mm.
CELL ISOLATION, EXPANSION, AND SEEDING
Meniscus tissue was collected according to an approved IRB protocol from 10 adult male and female patients ranging in age from 18 to 84 years (see Table I ). Resected tissue was finely minced and plated on tissue culture polystyrene in basal medium [Dulbecco's modified eagle medium (DMEM) containing 1Â Penicillin/Streptomycin/Fungizone (PSF) and 10% fetal bovine serum (FBS)]. MDCs emerged over a 2-week period after which the tissue pieces were removed. Adherent colonies were passaged twice to obtain >20 Â 10 6 cells for scaffold seeding. Mechanically homogeneous strips (5 mm wide by 75 mm long) were cut in the prevailing fiber direction of electrospun sheets and prepared for cellseeding 51, 52 . Strips were disinfected in ethanol (100, 70, 50, 30%; 30 min/ step), rinsed twice in phosphate-buffered saline (PBS), and soaked overnight in a 20 mg/ml human fibronectin (Invitrogen, Carlsbad, CA). Prior to seeding, strips were rinsed twice with PBS and segmented into three 25 mm long pieces, two of which were seeded with MDCs, leaving one to serve as a paired, unseeded control (USC). For seeding, each scaffold side received a 50 ml aliquot containing 250,000 cells followed by 1 h of incubation. After the final incubation, seeded constructs were cultured in 4 ml of chemically defined medium (high glucose DMEM with 1Â PSF, 0.1 mM dexamethasone, 50 mg/ml ascorbate 2-phosphate, 40 mg/ml L-proline, 100 mg/ml sodium pyruvate, 1Â ITSþ (6.25 mg/ml insulin, 6.25 mg/ml transferrin, 6.25 ng/ml selenous acid, 1.25 mg/ml bovine serum albumin, and 5.35 mg/ml linoleic acid) with 10 ng/ml transforming growth factor-b3 (TGF-b3) changed twice weekly) in non-tissue culture treated 6-well plates 61 . The USCs were incubated at 37 C in PBS changed twice monthly for the study duration.
MECHANICAL TESTING
Uniaxial tensile testing was performed with an Instron 5848 Microtester (Instron, Canton, MA). Prior to testing, five thickness measurements along the length of each sample were taken with a custom linear variable differential transformer (LVDT) measurement system; five width measurements were acquired with a digital caliper. Samples were clamped in serrated grips and a 0.5 N preload applied for 180 s to ensure proper seating. After noting gauge length with a digital caliper, samples were preconditioned by cyclic extension to 0.5% of the gauge length 0.1 Hz for 10 cycles. Subsequently, samples were extended beyond their yield point at a rate of 0.1% of the gauge length/s. For day 70 samples, extension was carried out until failure occurred. Stiffness was determined from the linear region of the forceeelongation curve. Using the cross-sectional area (CSA) and gauge length, Young's modulus was calculated from the analogous portion of the stressestrain curve. Five seeded samples were tested for each of the 10 donors at each time point along with their corresponding USCs.
BIOCHEMICAL ANALYSES
After mechanical testing, samples were stored at À80
C until determination of biochemical composition. Samples were lyophilized (Freezone 4.5 Freeze Dry System, LabConco, Kansas City, MO) for 24 h and massed to determine dry weights (DWs). Following this, samples were papain digested as in Ref. 61 and DNA, sulfated glycosaminoglycan (s-GAG), and collagen content was determined using the Picogreen double-stranded DNA (dsDNA) (Molecular Probes, Eugene, OR), dimethylmethylene blue (DMMB) dye-binding 62 , and hydroxyproline 63 assays, respectively. Hydroxyproline content was converted to collagen as in Ref. 64 , using a factor of 7.14. This conversion is an estimate, and susceptible to bias based on the prevailing collagen type present. Data are reported as a sample's total content or as a percentage of the sample DW. Five additional human meniscus samples (donor age 62 AE 6 years, all TKAs) were tested to establish native tissue biochemical content ranges.
HISTOLOGY
Cytoskeletal organization was examined in MDC monolayers and cellladen constructs 1 day post-seeding. Filamentous actin and nuclei were labeled with Alexa Flour 647 phalloidin and Prolong Gold Antifade with 4 0 ,6-diamidino-2-phenylindole (DAPI) (Invitrogen), respectively, and imaged at 20Â on a Nikon T30 inverted fluorescent microscope (Nikon Instruments, Inc., Melville, NY). For analysis of matrix deposition with long-term culture, a 6 mm length was cut from each paired, non-tested construct, fixed overnight at 4 C in 4% phosphate-buffered paraformaldehyde, and frozen in optimal cutting temperature compound (Sakura Finetek USA, Inc., Torrance, CA). Cross-sections, 8 mm thick (spanning the depth and width of the scaffold) were cut with a Cryostat (Microm HM500, MICROM International GmbH, Waldorf, Germany). Sections were rehydrated and stained with DAPI, Alcian Blue (AB, pH 1.0), or Picrosirius Red (PSR) to visualize cell 
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Results
CELL ISOLATION, EXPANSION, AND SCAFFOLD SEEDING
Cells were successfully isolated from meniscus tissue from each of the 10 donors (Table I) . A total of 20 Â 10 6 passage 2 cells were required from each donor for construct seeding. The time from initial plating to passage 2 confluency with sufficient expansion (>20 Â 10 6 cells) was 53 AE 9.6 days. Cell morphology (Fig. 1 ) during expansion showed an increasing population of fibroblast-like cells. When seeded onto aligned scaffolds, MDCs aligned their long axes and cytoskeleton with the scaffold architecture (Fig. 1) .
MECHANICAL PROPERTIES OF MDC-LADEN CONSTRUCTS
Mechanical properties of cell-seeded and paired acellular scaffolds were assessed via tensile testing. It was noted in preliminary studies that variations in scaffold mechanical properties exist both between different nanofibrous PCL batches, as well as along the length of the collection mandrel. For example, scaffold stiffness on day 14 (before appreciable matrix deposition) from different batches ranged from 2.7 to 6.1 N/mm (Table II) . To address the issue, each donor was assigned a specific production run of nanofibrous scaffold, and each MDC-seeded sample was tested along with an USC excised from the same location along the mandrel. As strips excised in such a manner begin with identical mechanical properties, the effect of cell-seeding and ECM deposition can be more accurately assessed. By normalizing the stiffness of each cell-seeded scaffold to its counterpart USC at each time point, a percentage change (as well as a magnitude change) in stiffness can be determined. The mechanical response of engineered constructs differed markedly between USCs and MDC-seeded constructs over the duration of the study. The forceedisplacement curve from each of the day 70 Donor 8 samples are shown in Fig. 2(A) , with MDC-laden constructs showing a much higher stiffness and ultimate load. Quantification of these changes amongst all donors revealed that the ultimate load [ Fig. 2(B) ] and stiffness [ Fig. 2(C) ] of cell-seeded samples increased for 8/10 donors and 10/10 donors by day 70, respectively (P < 0.001 vs USC). Conversely, USCs did not decrease over this same time course (P > 0.219 vs day 14). The average change in stiffness between day 14 and day 70 was 4.2 AE 2.1 N/mm for all donors, with a maximum change of 8.1 N/mm for Donor 8 and a minimum change of 1.6 N/mm for Donor 6 (Table II) . On a percentage basis, this represents changes of up to 300% in construct stiffness compared to USCs over the 70 days [ Fig. 2(C) ]. Cell-seeded constructs from each of the donors also increased in thickness (P < 0.05 except Donors 4 and 6), resulting in an increasing CSA (Table II, P < 0.05 except Donors 4 and 6). While moduli generally increased, the effect of the increase in CSA occasionally precluded these changes from reaching significance ( Table II) . The average change in modulus was 9.1 AE 6.8 MPa for all donors, with a maximum change of 21.6 MPa for Donor 8 and a minimum change of 0.8 MPa for Donor 9.
BIOCHEMICAL CONTENT OF MDC-LADEN CONSTRUCTS
Construct biochemical content was determined for cellseeded scaffolds with time in culture. Constructs seeded with MDCs from all donors increased in DW (Table III , P < 0.05 except Donor 2). This increase in mass ranged between 2.5 mg (Donor 4) and 6.1 mg (Donor 9) and averaged 4.5 AE 1.6 mg for all donors. DNA content also increased with time in culture (P < 0.001) for all donors except for Donor 10 (Table III) . Collagen and s-GAG contents also increased in constructs in a time-dependent manner [ Fig. 3(A and B) ]. Overall, the total s-GAG and collagen per construct was highly dependent on time in culture (P < 0.001) and donor (P < 0.001). We normalized these results to the DW of the construct [ Fig. 3(C and  D) ] to enable comparisons to the native tissue. For collagen, native tissue values averaged 50 AE 18% DW, and ranged from 24 to 72% DW [ Fig. 3(C), gray region] . s-GAG content of native tissue averaged 0.6 AE 0.3% DW, and ranged from 0.3 to 1.1% DW [ Fig. 3(D), gray region] . The most robust deposition of collagen (w18% DW, Donor 5) was lower than the lowest native tissue level, while the largest amount of s-GAG (w3.3% DW, Donor 7) was above native levels.
STRUCTUREeFUNCTION CORRELATIONS OF MDC-SEEDED CONSTRUCTS
Correlation analysis was carried out to determine the structureefunction relationships within developing constructs, and the relationship between donor age and capacity to generate increasing mechanical properties [ Fig. 4(AeC) ]. Strong correlations were found between the change in stiffness of the construct with the total collagen content [ Fig. 4(A) , R 2 ¼ 0.81 value, P < 0.001]. Weaker (but significant) correlations were also observed for change in stiffness with total s-GAG content [ Fig. 4(B) , R 2 ¼ 0.46, P < 0.001]. While there were significant differences in total DNA content between donors, no significant correlation was observed between this measure and mechanical performance (data not shown). Finally, correlating the change in stiffness with age showed Table III Biochemical composition of engineered meniscus constructs. Dry mass (mg), total DNA content (mg), total s-GAG content (mg), and total collagen content (mg) achieved on day 70 are provided for constructs generated from each of the 10 donors. Values indicate the mean (top number in bold) and standard deviation (bottom number) of five samples tested for each measure and donor at each time point. For each parameter, the highest magnitude of change is denoted with an (H), and lowest level of change is denoted with an (L). Average change in each parameter between days 14 and 70 for all donors is provided at the bottom of each column. All comparisons between days 14 and 70 were significantly different with P < 0.05 except when noted (þ). 
Discussion
In this study, we assessed the ability of human MDCs to modulate the properties of fiber-aligned biodegradable electrospun nanofibrous scaffolds. This scaffolding system serves as a 3D micro-pattern for directing cell orientation and neo-tissue formation by replicating the structural and mechanical anisotropy of the native tissue. Human MDCs were isolated from surgical waste from 10 human donors ranging in age from 18 to 84 and with differing disease status (acute vs degenerative meniscus tears, or progression of knee OA necessitating total joint replacement). MDCs were successfully isolated from each donor tissue, expanded in culture through passage 2, seeded onto scaffolds, and cultured in a chemically defined, pro-fibrocartilaginous medium formulation for 10 weeks. When seeded with MDCs, construct tensile properties, biochemical content, and histological features improved with time. Amongst the 10 donors, variations were observed in the magnitude of these quantitative and qualitative outcome measures, but each donor MDC population yielded positive maturation of the engineered construct. Those donors whose MDCs responded most vigorously generated well infiltrated constructs containing w20% of the collagen content of healthy native tissue with tensile moduli of w40 MPa. These findings indicate that native human MDCs derived from surgical debris are a potent cell source for the fabrication of mechanically functional engineered meniscus constructs.
We began this work with the hypothesis that MDCs derived from older individuals would harbor less capacity to generate functional properties in vitro. This idea was predicated on work demonstrating that in chondrocytes, a related cell type, collagen production decreases with age 58, 59 , and that disease states such as OA further reduce the matrix forming capacity 60 . In this study, MDCs were derived from the inner third of the meniscus (small avascular tears), the inner two-thirds of the meniscus (large tears or degenerate regions), or from the entirety of the meniscus (meniscus removal with TKA). These MDCs represented a range of donor ages, spanning 18e84 years. MDCs from the inner zone of the meniscus are considered chondrocyte-like, displaying phenotypic similarities including a round cell shape and cartilage gene expression and matrix deposition 23, 65 . Thus, these cells were expected to display age-dependent declines in ECM deposition capacity. However, counter our hypothesis, the age of donor MDCs showed no negative correlation with the properties of the engineered construct. In fact, in this study, change in stiffness and donor age showed a weak positive correlation. This finding is perhaps due to the fact that all donors were skeletally mature, while the most marked changes in cell biosynthetic activities occur at early ages. Interestingly, constructs with the most proteoglycan deposition, which one would expect for MDCs derived from the inner zone, actually came from Donor 9, who underwent a TKA and contributed cells from the entire meniscus. Obviously, these findings are drawn from a small set of donors, but analysis of this set reveals few strong indicators of robust growth based on standard parameters such as age and zonal source of donor cells.
In this study we focused on MDCs isolated from meniscectomy debris as a cell source for engineering replacement meniscus tissue. We focus on this overlooked cell source for a number of reasons outlined above (potential for autologuous therapies, no immune response, proper cell phenotype), and not on the more commonly used MSC. MSCs can undergo a fibrocartilaginous differentiation on nanofibrous scaffolds, as evidenced by increases in aggrecan and type II collagen expression and deposition 66 , and we have demonstrated similar growth and maturation patterns when using MSCs compared to MDCs in a juvenile bovine model system 52 . However, MSC isolation necessitates a second surgical site not associated with primary meniscus repair. Furthermore, we have recently shown that all regions of the meniscus contain multi-potential cells 67 , suggesting that endogenous cell populations may contribute to repair processes. The finding that all constructs improved in mechanical properties from 10 donors, points to the potential of MDCs as a cell source for meniscus tissue engineering. With surgery, the defect that is generated to alleviate acute symptoms may be accurately characterized. As the time between meniscus injury and the onset of OA is relatively long (5e10 years), a fully conforming construct may be fabricated and matured ex vivo to effect autologous repair.
In vitro culture of meniscus implants offers a range of benefits, most importantly the ability to optimize neo-tissue growth. In this study, we used a chemically defined medium containing TGF-b3 to promote fibrocartilaginous ECM deposition. In our previous studies with MDCs in both pellet format and when seeded onto nanofibrous scaffolds, this medium increased proteoglycan and collagen deposition 52, 67 . For a small subset of four donors, expression [assessed by real time polymerase chain reaction (PCR)] of aggrecan and type I collagen was constant or increased over the culture duration, while type II collagen expression increased markedly, perhaps reflecting the reversal of dedifferentiation events that had occurred as result of monolayer expansion (data not shown). For the repair of defects in the inner avascular meniscus zone (the most common site of injury in middle-aged patients), engineered constructs would ideally match the biochemical composition of the native tissue. This zone contains the largest level of proteoglycan, and a mixture of type I and type II collagens 21 . For MDCs from all donors, GAG levels matched or were superior to native tissue. Correlations between measured GAG content and tensile properties showed only a weak correlation. Conversely, collagen content of constructs formed from all donors increased substantially, and reached a maximum of 18% DW, though a range is observed in samples derived from differing states of meniscal degeneration. Correlation analysis showed a very strong association between collagen deposition in constructs and the tensile properties. This suggests that maximizing the collagen content of constructs may further improve their tensile properties.
While the results of this study are promising, there are several limitations that should be addressed. First, significant variations were observed in the properties achieved amongst the 10 donors. Age does not appear to be the prevailing indicator, and so other predictors of growth potential must be developed to identify suitable donors, such as short-term screening in pellet cultures prior to scaffold seeding. Furthermore, while some constructs approached moduli of 40 MPa within 10 weeks, further enhancement of this and other mechanical properties toward native tissue values is a priority. Another potential limiting factor is the persistence of the polymer fibers, which may impede complete cellular infiltration. While the volume fraction of polymer in these scaffolds is in the range of 10e20% 51 , small pores may slow matrix filling. Inclusion of faster degrading polymer elements, such as poly(lactic-co-glycolic acid) (PLGA) 55 , or biologic fiber components such as collagen 68 , into the fibrous network may speed this infiltration process. Alternatively, infiltration may be enhanced by creating a mixture of fiber sizes 69 , utilizing salt leaching approaches to create large pores/lamellae 70 , or as in our recent approach, evacuating sacrificial fibers to enhance porosity while maintaining overall structural anisotropy 71 . As a final note, we created constructs as rectangular strips to facilitate tensile testing, without considering the wedge-shaped anatomic form of the meniscus. For clinical application, engineering and fabrication technologies must be developed to enable reproduction of the anatomic form, and integration with native tissue must be achieved 72 . To this end, we have recently demonstrated that MDCseeded multi-lamellar constructs form mechanically viable interfaces when held in apposition with one another 73 and with the native tissue 74 , and that the constructs hold suture 75 allowing fixation within a meniscus defect. Regardless of these advances, complete integration will be a significant challenge 76 , and strategies that engage the outer vascular periphery 77 maybe be required to enable in vivo success. Long-term in vivo studies will address this question in detail, and explore the ability of these novel constructs to preserve articular cartilage and avert the onset of OA after partial meniscectomy.
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